IPO comprises a fresh issue of 45,84,000 equity shares with a face value of Rs. 10 each In December 2023, Nephro Care India Limited successfully closed the pre-IPO funding round, which saw the participation of banking veteran and former chairman of HDFC Ltd, Deepak
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy Venus Remedies is among the largest Indian exporters of these drugs Ukraine is among the largest countries in Europe and its pharmaceutical market has been witnessing
Emerges as the ONLY Healthcare Marketing Platform that ensures Real-Time Programmatic message delivery across POC platforms triggered by clinical data, AT SCALE The largest global marketing platform to reach 5 M+ HCPs across 25+ countries through 4000+ marketing campaigns Doceree, the leading global healthcare
Indian pharma companies are incorporating AI algorithms into their R&D operations, clinical trials and streamlining processes Firms deploying GenAI are seeing reduction in early-stage drug development costs, and improvement in operational efficiencies EY Parthenon (EY-P), the leading strategy consulting firm, in partnership with BioAsia,
Company reports resilient performance in the nine months to date: revenue from operations up 17% to Rs 2,572 crores, PAT up 16% to Rs 330 crores (before exceptional items) Syngene International Limited today announced its third quarter financial results. Reported revenue from operations for the quarter
Thermo Fisher Scientific, the world leader in serving science, announces the appointment of Srinath Venkatesh as Managing Director, India and South Asia, for the company. Srinath Venkatesh steps into this pivotal role with a vision to advance Thermo Fisher's growth and operations in India, while enhancing
The funds will be utilized to expand HempStreet’s product range and further build upon the company’s capabilities towards solving menstrual (Dysmenorrhea) pain -The company projects a 100% revenue growth for the financial year 2023 -24 HempStreet, India's first research to retail venture in the ayurvedic cannabis sector, has raised
Need for stronger private collaborations, community engagement to extend healthcare access to every women: Additional Secretary & DG (CGHS), MoHFW Ms Roli Singh, Additional Secretary & DG (CGHS), Ministry of Health and Family Welfare, Govt of India while applauding the progress made so far in terms of
Obtaining market authorization for Bleomycin from MHRA is a momentous accomplishment for Venus Pharma GmbH. Venus Remedies holds a total of 15 Market Authorizations (MA) for Bleomycin products across the globe. Venus Remedies is thrilled to announce the achievement of market authorization in the United Kingdom
Program partners with government hospitals to strengthen drug development in the country Roche Pharma India, world’s leading biopharmaceutical company today announced the launch of its Clinical Trial Excellence project in India with an objective to strengthen the capabilities of public health institutions to do clinical trials
